Our team relies on its many years of experience and past successes, to prepare and execute numerous technology transfers for the manufacture of hyaluronic acid products (cross-linked or non-cross-linked HA), in Europe but also outside Europe, particularly in China and the Middle East. These operations have led us in particular to improve the pre-existing technologies at our customers, scale up and provide them with more modern technologies.
Company
Technology transfer
Explore our environment
-
SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26
The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…
-
Inauguration of Syrhatech’s new premises in Geneva
The Syrhatech team was delighted to share a convivial moment on its terrace on the…
-
Development of a specific syringe for wrinkle filler
Our customer contacts us to validate the design of a syringe made of plastic by…
-
Development of an innovative gel with very high concentration
Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…
-
Technology transfer
Our team relies on its many years of experience and past successes, to prepare and…
-
Development of a cross-linked HA formulation containing peptides
At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…
-
Development of a cross-linked hydrogel similar to an existing product
Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…
-
Formulation of a new polymer
Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…
